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A few reports have now established that the cat
scratch disease agent Bartonella henselae is respon-
sible for uveitis [1]. Bartonella grahamii has also
been recognized as being responsible for uveitis
[2]. However, the prevalence of Bartonella uveitis
remains poorly known, as is the potential role of
other Bartonella species.
Prospective evaluation of a standardized labo-
ratory protocol for the diagnosis of uveitis of
unknown aetiology [3] showed that Bartonella
species were responsible for most cases of bacte-
rial uveitis. Prominent clinical features and labo-
ratory diagnosis data of this large series are
reported herein.
This study was approved by the Ethics Com-
mittee of our institution; patients with a known
aetiological diagnosis and patients with ophthal-
mological features pathognomonic of an aetiol-
ogy, such as toxoplasmosis, were not eligible. A
questionnaire was used for the collection of data,
and was anonymized before the study according
to French law. Informed consent for inclusion was
obtained from patients and parents or legal
guardians of children (i.e. age <18 years). Uveitis
was classiﬁed according to the international uve-
itis study group deﬁnition and classiﬁcation. Five
millilitres of serum and ocular ﬂuid were col-
lected aseptically, by anterior chamber paracen-
tesis or vitreous tap ⁄ vitrectomy. Serum was
tested for the presence of antibody against
B. henselae Houston and Marseille serotypes,
Bartonella quintana and B. grahamii using micro-
immunoﬂuorescence and Western blot [4]. After
lysis, nucleic acids were isolated using the tissue
kit and the Magna-Pure apparatus, according to
the instructions of the supplier (Roche Applied
Science, Indianapolis, IN, USA). Intra-ocular spec-
imens from deceased patients without infection
from the Marseilles area as well as water and mix
samples were used as negative controls. One
negative control was used for eight specimens,
and any false-positive control annulled the valid-
ity of the assay. A nested PCR targeting the
Bartonella hbpE gene, using primer pair 5¢-GAGA-
GTGCTTCACCTAAATAG-3¢ and 5¢-CCAC-
CAATCTGTCCTCCAAA-3¢, was performed. The
diagnosis of Bartonella uveitis was considered as
deﬁnite if: (i) positive PCR with an identifying
sequence was obtained from ocular ﬂuid; and (ii)
the antibody level was ‡1 : 100 by microimmu-
noﬂuorescence or there were ‡2 speciﬁc bands in
Western blot for Bartonella spp.
Between January 2001 and April 2008, 1520
intra-ocular and serum specimens collected from
1417 patients were analysed. Bartonella spp. infec-
tion was diagnosed in 31 (2.6%) patients, by
speciﬁc molecular testing of intra-ocular speci-
mens only in four patients, and by Western blot
only in ten patients. Uveitis was due to B. henselae
in 17 patients, B. quintana in seven patients,
B. grahami in four patients, and undetermined
Bartonella spp. in three patients (Table 1). All
cases of B. henselae uveitis were due to the
Houston genotype as determined by sequencing
PCR products or by Western blot analysis.
In our series, Bartonella spp. ranked second
after spirochaetes among the fastidious pathogens
responsible for uveitis. Characteristic stellar reti-
nitis was found in nine of 31 (29%) patients, but
clinical features were otherwise non-speciﬁc, with
uveitis being posterior in 18 of 31 (58%) patients,
anterior in nine of 31 (29%), intermediate in two
of 31 (6.5%), and panuveitis in two of 31 (6.5%).
Patients presented with non-granulomatous uve-
itis in 18 of 31 (58%) cases and granulomatous
uveitis in 13 of 31 (42%) cases. Contacts with
animals were notable in 11 of 31 (35.5%) patients.
In most patients, the diagnosis was made by
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immunoﬂuorescence serology incorporating three
different Bartonella species as the antigens, but
Western blot serology was the sole diagnostic test
in one-third of patients. Indeed, for most patients
previously diagnosed with B. henselae uveitis [1],
the diagnosis has been made on the basis of a
single, elevated anti-B. henselae serum antibody
titre by using immunoﬂuorescence or ELISA
techniques [1]. Because of cross-reactivity be-
tween B. henselae and other microorganisms
responsible for uveitis, and as the seroprevalence
of B henselae in uveitis patients was similar to that
in the general population as determined using
ELISA, these diagnoses remained presumptive
[5]. In our series, positive immunoﬂuorescence
serology was conﬁrmed by Western blot analysis
[4]. This approach increased the speciﬁcity of the
test and allowed species identiﬁcation. We sero-
logically found only the Houston serotype,
whereas one patient with PCR detection exhibited
a Marseille genotype [3]. On the basis of ELISA
and immunoﬂuorescence serology only, the fre-
quency with which infections with Bartonella
species other than B. henselae produces uveitis
was previously unknown. In our series, 43% of
cases were due to B. henselae and one-third to
B. quintana; the latter pathogen has not been
previously documented in uveitis, in contrast to
B. grahamii, which has been found in four patients
and previously reported as a causative agent of
uveitis [2]. In three patients, the causative Barto-
nella species was not determined.
These data indicate that patients presentingwith
uveitis of unknown aetiology should be tested for
Bartonella species. Laboratory investigation should
include Western blot analysis of serum. Speciﬁc
PCR-based detection of Bartonella spp. DNA
should be performed if an intra-ocular specimen
is available. B. quintana should be added to the list
of Bartonella species responsible for uveitis.
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Table 1. Clinical features of 31 patients with Bartonella spp. uveitis
No. Aetiology Age (years) Sex Localization Classiﬁcation Contacts with animals Type of inﬂammation Stellar retinitis Vasculitis Choroiditis Papillitis
1 B. henselae 40 F Bilateral Anterior + Granulomatous ) + ) +
2 B. henselae 10 M Bilateral Anterior ) Granulomatous ) ) +
3 B. quintana 74 F Unilateral Posterior ) Granulomatous + + ) +
4 B. henselae 35 M Bilateral Posterior ) Non-granulomatous + + ) )
5 B. henselae 61 F Unilateral Posterior + Non-granulomatous ) ) ) )
6 B. grahamii 64 M Bilateral Anterior ) Granulomatous ) ) ) +
7 B. quintana 30 F Unilateral Anterior ) Non-granulomatous ) ) ) )
8 B. quintana 35 M Bilateral Anterior ) Granulomatous ) ) ) )
9 Bartonella sp. 48 M Bilateral Posterior + Granulomatous ) ) ) )
10 B. henselae 13 F Unilateral Intermediate ) Granulomatous ) ) +
11 B. henselae 39 M Unilateral Anterior ) Non-granulomatous ) ) )
12 B. henselae 31 F Bilateral Intermediate ) Granulomatous ) ) ) )
13 B. quintana 19 M Unilateral Posterior + Non-granulomatous + ) ) )
14 B. quintana 7 F Unilateral Anterior ) Non-granulomatous ) ) ) )
15 B. quintana 9 F Bilateral Anterior + Non-granulomatous ) ) ) )
16 B. grahamii 33 M Unilateral Posterior + Granulomatous + ) ) +
17 B. henselae 41 F Unilateral Posterior ) Granulomatous ) + ) )
18 B. henselae 28 F Unilateral Posterior ) Non-granulomatous + ) +
19 B. quintana 42 M Bilateral Posterior ) Granulomatous ) ) ) )
20 B. grahamii 14 F Unilateral Posterior ) Non-granulomatous ) ) ) )
21 B. grahamii 23 F Bilateral Posterior + Non-granulomatous + + ) )
22 Bartonella sp. 37 M Unilateral Posterior ) Non-granulomatous ) ) ) )
23 B. henselae 40 M Unilateral Posterior ) Non-granulomatous + ) ) )
24 B. henselae 11 M Unilateral Posterior + Non-granulomatous + ) ) )
25 B. henselae 62 F Unilateral Posterior ) Non-granulomatous ) ) ) +
26 B. henselae 85 F Bilateral Posterior ) Granulomatous ) ) ) )
27 B. henselae 5 M Bilateral Posterior + Non-granulomatous + ) ) )
28 B. henselae 16 F Unilateral Anterior ND Non-granulomatous ) ) ) +
29 B. henselae 86 F Unilateral Panuveitis ) Non-granulomatous
30 B. henselae 45 M Bilateral Panuveitis + Granulomatous ) ) + )
31 Bartonella sp. 34 M Unilateral Posterior + Non-granulomatous + ) ) )
ND, not determined.
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